Glatiramer acetate and Injection site pain - a phase IV clinical study of FDA data
Summary:
We study 4,688 people who have side effects when taking Glatiramer acetate. Injection site pain is found, especially among people who are female, 30-39 old, have been taking the drug for 1 - 6 months, also take Copaxone and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people take Glatiramer acetate and have Injection site pain. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,688 people reported to have side effects when taking Glatiramer acetate.
Among them, 752 people (16.04%) have Injection site pain.
What is Glatiramer acetate?
Glatiramer acetate has active ingredients of glatiramer acetate. Currently, eHealthMe is studying from 4,693 Glatiramer acetate users.
What is Injection site pain?
Injection site pain is found to be associated with 2,736 drugs and 1,897 conditions by eHealthMe. Currently, we are studying 260,817 people who have Injection site pain.
Number of Glatiramer acetate and Injection site pain reports submitted per year:
Time on Glatiramer acetate when people have Injection site pain *:
Gender of people who have Injection site pain when taking Glatiramer acetate*:
Age of people who have Injection site pain when taking Glatiramer acetate *:
Common drugs people take besides Glatiramer acetate *:
Common side effects people have besides Injection site pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Glatiramer acetate and have Injection site pain?
Check whether Injection site pain is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Related studies
Glatiramer acetate side effects by duration, gender and age:
- Glatiramer acetate side effects (4,693 reports)
Injection site pain treatments and more:
- Injection site pain (260,817 reports)
Common drugs associated with Injection site pain:
- Enbrel: 58,863 reports
- Humira: 50,549 reports
- Methotrexate: 15,092 reports
- Repatha: 9,695 reports
- Trulicity: 7,970 reports
- Prednisone: 7,794 reports
- Metformin: 7,046 reports
- Dupixent: 5,925 reports
- Forteo: 5,429 reports
- Sandostatin: 5,142 reports
All the drugs that are associated with Injection site pain:
- Injection site pain (2,736 drugs)
Common conditions associated with Injection site pain:
- Rheumatoid arthritis: 50,275 reports
- Psoriasis: 19,102 reports
- Crohn's disease: 14,914 reports
- Multiple sclerosis: 12,289 reports
- Type 2 diabetes: 11,618 reports
- High blood cholesterol: 9,881 reports
- Ankylosing spondylitis: 6,265 reports
- Osteoporosis: 5,409 reports
- High blood pressure: 5,383 reports
All the conditions that are associated with Injection site pain:
- Injection site pain (1,897 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Glatiramer acetate) and Glatiramer acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Depakote Er and Zoloft drug interaction - 2 seconds ago
- Cleocin Phosphate and Lithium Carbonate drug interaction - 3 seconds ago
- Candesartan Cilexetil and Metabolic Acidosis - 3 seconds ago
- Namenda Xr and Sertraline drug interaction - 6 seconds ago
- Depakote and Hypothyroidism - 8 seconds ago
- Codeine and Paleness - 12 seconds ago
- Thiamine Hydrochloride and Betamethasone Valerate drug interaction - 17 seconds ago
- Clonidine Hydrochloride and Ondansetron Hydrochloride drug interaction - 20 seconds ago
- Diazepam and Initial Insomnia - 28 seconds ago
- Furosemide and Infection Susceptibility Increased - 28 seconds ago